Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sibylle Loibl

Showing results (1-10 of 449) with videos related to

Pageof 45
Sort By:
Current Opinion in Obstetrics & Gynecology|December 10, 2014
Neoadjuvant treatment of breast cancer: maximizing pathologic complete response rates to improve prognosisSibylle Loibl
Breast Care (Basel, Switzerland)|September 9, 2010
New Therapeutic Options for Breast Cancer during PregnancySibylle Loibl
JAMA Oncology|July 17, 2015
The Dual Role of Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Two Sides of the Same Coin?Sibylle Loibl
Cancer Treatment and Research|July 14, 2009
Adjuvant therapy in patients with breast cancer during pregnancySibylle Loibl
The Lancet. Oncology|March 7, 2018
Neoadjuvant chemotherapy for early breast cancerDavid Krug, Sibylle Loibl
JAMA|October 27, 2011
Gonadotropin-releasing hormone analogue for premenopausal women with breast cancerSibylle Loibl, Bernd Gerber
The Lancet. Oncology|December 21, 2019
CDK4/6 inhibitors in breast cancer: one more step towards reduced mortalityGiuseppe Curigliano, Sibylle Loibl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
How Much Information Do We Really Need After Neoadjuvant Therapy for Breast Cancer?Sibylle Loibl, Carsten Denkert
Breast (Edinburgh, Scotland)|December 21, 2021
Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancerSibylle Loibl, Jenny Furlanetto
Breast Care (Basel, Switzerland)|August 11, 2020
Optimal Systemic Treatment for Early Triple-Negative Breast CancerJenny Furlanetto, Sibylle Loibl
Pageof 45

Showing results (1-10 of 449) with videos related to

Sort By:
Pageof 45
Current Opinion in Obstetrics & Gynecology|December 10, 2014
Neoadjuvant treatment of breast cancer: maximizing pathologic complete response rates to improve prognosisSibylle Loibl
Breast Care (Basel, Switzerland)|September 9, 2010
New Therapeutic Options for Breast Cancer during PregnancySibylle Loibl
JAMA Oncology|July 17, 2015
The Dual Role of Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Two Sides of the Same Coin?Sibylle Loibl
Cancer Treatment and Research|July 14, 2009
Adjuvant therapy in patients with breast cancer during pregnancySibylle Loibl
The Lancet. Oncology|March 7, 2018
Neoadjuvant chemotherapy for early breast cancerDavid Krug, Sibylle Loibl
JAMA|October 27, 2011
Gonadotropin-releasing hormone analogue for premenopausal women with breast cancerSibylle Loibl, Bernd Gerber
The Lancet. Oncology|December 21, 2019
CDK4/6 inhibitors in breast cancer: one more step towards reduced mortalityGiuseppe Curigliano, Sibylle Loibl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
How Much Information Do We Really Need After Neoadjuvant Therapy for Breast Cancer?Sibylle Loibl, Carsten Denkert
Breast (Edinburgh, Scotland)|December 21, 2021
Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancerSibylle Loibl, Jenny Furlanetto
Breast Care (Basel, Switzerland)|August 11, 2020
Optimal Systemic Treatment for Early Triple-Negative Breast CancerJenny Furlanetto, Sibylle Loibl
Pageof 45